1Klint M,Lofdahl,M.Ek C,et al.Lymphogranuloma venereum prevalence in Sweden among men who have sex with men and characterization of Chlamydia trachomatis ompA genotypes[J].J Clin Microbiol,2006,44(11):4066-40671.
4Geisler WM,Suchland RJ,Whittington W L,et al.The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection[J].Sex Transm Dis,2003,30(2):160-165.
5Gao Xing,Chen Xiang-Sheng,Yin Yue-Ping,et al.Distribution Study of Chlamydia trachomatis Serovars among High-Risk Women in China Performed Using PCR-Restrietion Fragment Length PolymorPhism Genotyping[J].J Clin Mierobiol,2007,45(4):1185-1189.
6Lyons J M,Morre SA,Airo-Brown lP,et al.Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice[J].BMC Infect Dis,2005,5:105.
7Anttila T,Saikku P,Koskela P,et al.Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma[J].JAMA,2001,285(1):47-51.
8Zenilman JM.Chlamydia and cervical cancer:a real association?[J].JAMA,2001,285(1):81-83.
9Madeleine MM,Anttila T,Schwartz SM,et al.Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology,HPV type and HPV cofactors[J].Int J Cancer,2007,120(3):650-655.
10Lyons JM,Ito JI Jr,Morre S A,et al.Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model:host factors as major determinants of C trachomatis mediated pathogenesis[J].J Clin Pathol,2004,57(6):657-659.
二级参考文献18
1颜子颖 王海林.精编分子生物学实验指南[M].北京:科学出版社,1998.17-287.
2Fletcher HM,Schenkein HA,Morgan RM,et al.Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene.Infect Immun,1995,63(4):1521-1528.
3Ali RW,Martin L,Haffajee AD,et al.Detection of identical ribotypes of Porphyromonas gingivalis in patients residing in the United States,Sudan,Romania and Norway.Oral Microbiol Immunol,1997,12:106-111.
4Abaibou H,Chen Z,Olango GJ,et al.VimA gene downstream of recA is involved in virulence modulation in Porphyromonas gingivalis W83.Infection and Immunity,2001,69(1):325-335.
5Schenkein HA,Fletcher HM,Bodnar M,et al.Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins.J Immunol,1995,154:5331-5337.
6Barkocy-Gallagher GA,Han N,Patti JM,et al.Analysis of the prtP Gene Encoding Porphypain,a Cysteine Proteinase of Porphyromonas gingivalis J Gallagher Bacteriol,1996,178(10):2734-2741.
7Hideo Yonezawa,Kazuyuki.Arg-gingipain A DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model.J Immunity,2001,2858-2864.
8Lamont RJ,Jenkinson HF.Life below the gum line:pathogenic mechanisms of Porphyromonas gingivalis.MMBR,1998,62(4):1092-2172.
9Selander RK,Musser JM,Caugant DA.Population genetics of pathogenic bacteria.Microb Path,1987,3:1-7.
10Fletcher HM,Schenkein HA,Macrina FL.Cloning and characterization of a new protease gene (prtH) from Porphyromonas gingivalis.Infect Immun,1994,62(10):4279-4286.
